Advance Solid Tumors clinical trials

Explore recruiting advance solid tumors clinical trials.

Recruiting advance solid tumors studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Advance Solid Tumors trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A first-in-human, Phase 1/2, open-label, multi-center, dose-escalation, dose-optimization, and dose-expansion study to evaluate the safety, tolerability, pharmacokinetics, pharmacodynamics, and anti-tumor activity of PARP1 selective inhibitor, EIK1003 (IMP1734), as monotherapy and in combination in participants with advanced solid tumors.

France, Spain, Denmark

Phase I and Phase II (Integrated)- First administration to humans EU CTIS Study details

A Phase 1/2a, Open-label, Dose-finding Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of BMS-986507 (BL-B01D1) combinations in Adult Participants with Advanced Solid Tumors

Netherlands, Spain, France, Italy

Phase I and Phase II (Integrated)- Other EU CTIS Study details

Phase I/Ib clinical trial of PM54 in Advance Solid Tumors patients

Spain, Belgium, France

Phase I and Phase II (Integrated)- First administration to humans EU CTIS Study details

A phase Ib/II open-label, multi-center dose escalation study of JDQ443 in patients with advanced solid tumors harboring the KRAS G12C mutation

Netherlands, Spain, Germany, France, Belgium, Italy +1 more

Phase I and Phase II (Integrated)- First administration to humans EU CTIS Study details

Advance Solid Tumors trials by city

Advance Solid Tumors in Toronto Advance Solid Tumors in Vancouver Advance Solid Tumors in Montreal Advance Solid Tumors in Calgary Advance Solid Tumors in Edmonton Advance Solid Tumors in Ottawa Advance Solid Tumors in Winnipeg Advance Solid Tumors in Quebec City Advance Solid Tumors in Hamilton Advance Solid Tumors in Kitchener Advance Solid Tumors in London Advance Solid Tumors in Halifax Advance Solid Tumors in New York Advance Solid Tumors in Los Angeles Advance Solid Tumors in Chicago Advance Solid Tumors in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease